Cited by 367Cannabis and Cannabinoid ResearchGut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.

Endocannabinoids–at the crossroads between the gut microbiota and host metabolism

Cani, Patrice D., Plovier, Hubert, Van Hul, Matthias, Geurts, Lucie, Delzenne, Nathalie M., Druart, Céline, Everard, Amandine·2016·Nature Reviews Endocrinology

DOI 10.1038/nrendo.2015.211

Open this paper in CoChat — free account

Abstract

Various metabolic disorders are associated with changes in inflammatory tone. Among the latest advances in the metabolism field, the discovery that gut microorganisms have a major role in host metabolism has revealed the possibility of a plethora of associations between gut bacteria and numerous diseases. However, to date, few mechanisms have been clearly established. Accumulating evidence indicates that the endocannabinoid system and related bioactive lipids strongly contribute to several physiological processes and are a characteristic of obesity, type 2 diabetes mellitus and inflammation. In this Review, we briefly define the gut microbiota as well as the endocannabinoid system and associated bioactive lipids. We discuss existing literature regarding interactions between gut microorganisms and the endocannabinoid system, focusing specifically on the triad of adipose tissue, gut bacteria and the endocannabinoid system in the context of obesity and the development of fat mass. We highlight gut-barrier function by discussing the role of specific factors considered to be putative 'gate keepers' or 'gate openers', and their role in the gut microbiota-endocannabinoid system axis. Finally, we briefly discuss data related to the different pharmacological strategies currently used to target the endocannabinoid system, in the context of cardiometabolic disorders and intestinal inflammation.

Integrity signals

Registry

Crossref · 10.1038/nrendo.2015.211

Cites

156 of 156 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Untitled work
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Self-citation
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.004 · Cited by 3,315
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Animals in a bacterial world, a new imperative for the life sciences
McFall‐Ngai, M., Hadfield, M. G., Bosch, T. C. G., Carey, H. V., Domazet‐Lošo, T., Douglas, A. E., Dubilier, N., Eberl, G., Fukami, T., Gilbert, S. F., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218525110 · Cited by 2,879
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436
Alterations of the human gut microbiome in liver cirrhosis
Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., Guo, J., Le Chatelier, E., Yao, J., Wu, L., et al. (2014) · Nature · doi:10.1038/nature13568 · Cited by 2,177
Prebiotic effects: metabolic and health benefits
Roberfroid, M. B., Gibson, G. R., Hoyles, L., McCartney, A. L., Rastall, R. A., Rowland, I. R., Wolvers, D. A. W., Watzl, B., Szajewska, H., Stahl, B., et al. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510003363 · Cited by 2,170
An integrated catalog of reference genes in the human gut microbiome
MetaHIT Consortium, Li, J., Jia, H., Cai, X., Zhong, H., Feng, Q., Sunagawa, S., Arumugam, M., Kultima, J. R., Prifti, E., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2942 · Cited by 2,164
Artificial sweeteners induce glucose intolerance by altering the gut microbiota
Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C. A., Maza, O., Israeli, D., Zmora, N., Gilad, S., Weinberger, A., et al. (2014) · Nature · doi:10.1038/nature13793 · Cited by 2,067
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
Chassaing, B., Koren, O., Goodrich, J. K., Poole, A. C., Srinivasan, S., Ley, R. E., & Gewirtz, A. T. (2015) · Nature · doi:10.1038/nature14232 · Cited by 2,055
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
Dao, M. C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E. O., Kayser, B. D., Levenez, F., Chilloux, J., Hoyles, L., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308778 · Cited by 1,931
Worlds within worlds: evolution of the vertebrate gut microbiota
Ley, R. E., Lozupone, C., Hamady, M., Knight, R. D., & Gordon, J. I. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1978 · Cited by 1,697
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Marzo, V. D., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,666
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
Gaal, L. F. V., Rissanen, A., Scheen, A. J., Ziegler, O., & Rössner, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66374-x · Cited by 1,511
The composition of the gut microbiota throughout life, with an emphasis on early life
Rodríguez, J. M., Murphy, K., Stanton, C., Ross, R. P., Kober, O. I., Juge, N., Avershina, E., Rudi, K., Narbad, A., Jenmalm, M. C., et al. (2015) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v26.26050 · Cited by 1,414
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
Cota, D., Marsicano, G., Tschöp, M. H., Grübler, Y., Flachskamm, C., Schubert, M. I., Auer, D. P., Yassouridis, A., Thöne‐Reineke, C., Ortmann, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17725 · Cited by 1,168
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
Osei‐Hyiaman, D., DePetrillo, M. A., Pacher, P., Liu, J., Radaeva, S., Bátkai, S., Harvey-White, J. D., Mackie, K., Offertáler, L., Wang, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23057 · Cited by 1,131
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H., & Astrup, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61721-8 · Cited by 1,097
The role of the gut microbiota in energy metabolism and metabolic disease
Cani, P., & Delzenne, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168164 · Cited by 974
Self-citation
Towards a more comprehensive concept for prebiotics
Bindels, L. B., Delzenne, N. M., Cani, P. D., & Walter, J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.47 · Cited by 914
Defining a Healthy Human Gut Microbiome: Current Concepts, Future Directions, and Clinical Applications
Bäckhed, F., Fraser, C. M., Ringel, Y., Sanders, M. E., Sartor, R. B., Sherman, P. M., Versalovic, J., Young, V., & Finlay, B. B. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.10.012 · Cited by 836
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1521 · Cited by 793
An anorexic lipid mediator regulated by feeding
de Fonseca, F. R., Navarro, M. A., de Heras, R. G., Escuredo, L., Nava, F. A., Fu, J., Murillo‐Rodríguez, E., Giuffrida, A., LoVerme, J., Gaetani, S., et al. (2001) · Nature · doi:10.1038/35102582 · Cited by 695
The endocannabinoid system links gut microbiota to adipogenesis
Muccioli, G. G., Naslain, D., Bäckhed, F., Reigstad, C. S., Lambert, D. M., Delzenne, N. M., & Cani, P. D. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.46 · Cited by 691
Endocannabinoid signaling at the periphery: 50 years after THC
Maccarrone, M., Bab, I., Bíró, T., Cabral, G. A., Dey, S. K., Marzo, V. D., Konje, J. C., Kunos, G., Mechoulam, R., Pacher, P., et al. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.008 · Cited by 677
Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and β-Pancreatic Cells and in Obesity and Hyperglycemia
Matias, I., Gonthier, M., Orlando, P., Martiadis, V., PETROCELLIS, L. D., Cervino, C., Petrosino, S., Hoareau, L., Festy, F., Pasquali, R., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2679 · Cited by 654
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity
Ben‐Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M. H., Vogel, Z., Bisogno, T., PETROCELLIS, L. D., Marzo, V. D., & Mechoulam, R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00392-6 · Cited by 650
Anandamide and vanilloid TRPV1 receptors
Ross, R. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705467 · Cited by 603
Glucagon-Like Peptides
Drucker, D. J. (1998) · Diabetes · doi:10.2337/diab.47.2.159 · Cited by 598
Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles
Hopkins, M. J., Sharp, R., & Macfarlane, G. T. (2001) · Gut · doi:10.1136/gut.48.2.198 · Cited by 577
The Gut Microbiota of Rural Papua New Guineans: Composition, Diversity Patterns, and Ecological Processes
Martínez, I., Stegen, J. C., Maldonado-Gómez, M. X., Eren, A. M., Siba, P. M., Greenhill, A. R., & Walter, J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.049 · Cited by 576
The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
Silvestri, C., & Marzo, V. D. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.001 · Cited by 575
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
Osei‐Hyiaman, D., Liu, J., Zhou, L., Godlewski, G., Harvey-White, J. D., Jeong, W., Bátkai, S., Marsicano, G., Lutz, B., Buettner, C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34827 · Cited by 474
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Tam, J., Vemuri, K. V., Liu, J., Bátkai, S., Mukhopadhyay, B., Godlewski, G., Osei‐Hyiaman, D., Ohnuma, S., Ambudkar, S. V., Pickel, J. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42551 · Cited by 470
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
Marrs, W., Blankman, J. L., Horne, E. A., Thomazeau, A., Lin, Y. H., Coy, J. W., Bodor, Á. L., Muccioli, G. G., Hu, S. S., Woodruff, G., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2601 · Cited by 460
Cannabinoids and the gut: New developments and emerging concepts
Izzo, A. A., & Sharkey, K. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.005 · Cited by 434
GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell
Lauffer, L. M., Iakoubov, R., & Brubaker, P. L. (2009) · Diabetes · doi:10.2337/db08-1237 · Cited by 405
Endocannabinoid signalling and the deteriorating brain
Marzo, V. D., Stella, N., & Zimmer, A. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3876 · Cited by 395
The gut microbiome as therapeutic target
Cani, P. D., & Delzenne, N. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.012 · Cited by 365
Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
Tam, J., Çınar, R., Liu, J., Godlewski, G., Wesley, D., Jourdan, T., Szanda, G., Mukhopadhyay, B., Chedester, L., Liow, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.002 · Cited by 356
Altered Gut Microbiota and Endocannabinoid System Tone in Obese and Diabetic Leptin-Resistant Mice: Impact on Apelin Regulation in Adipose Tissue
Geurts, L., Lazarević, V., Derrien, M., Everard, A., Roye, M. V., Knauf, C., Valet, P., Girard, M., Muccioli, G. G., François, P., et al. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00149 · Cited by 335
Differential Expression of Cannabinoid Receptors in the Human Colon: Cannabinoids Promote Epithelial Wound Healing
Wright, K. L., ROONEY, N., Feeney, M., Tate, J. J. T., Robertson, D. A., Welham, M. J., & Ward, S. G. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.026 · Cited by 311
Possible endocannabinoid control of colorectal cancer growth
Ligresti, A., Bisogno, T., Matias, I., PETROCELLIS, L. D., Cascio, M. G., Cosenza, V., D’Argenio, G., Scaglione, G., Bifulco, M., Sorrentini, I., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00881-3 · Cited by 288
Gut microbiota and GLP-1
Everard, A., & Cani, P. D. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9288-6 · Cited by 279
Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity
Chen, Z., Guo, L., Zhang, Y., L. Walzem, R., Pendergast, J. S., Printz, R. L., Morris, L. C., Matafonova, E., Stien, X., Kang, L., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72517 · Cited by 277
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation
Esposito, G., Capoccia, E., Turco, F., Palumbo, I., Lu, J., Steardo, A., Cuomo, R., Sarnelli, G., & Steardo, L. (2013) · Gut · doi:10.1136/gutjnl-2013-305005 · Cited by 269
The Religious and Medicinal Uses of Cannabis in China, India and Tibet
Touw, M. (1981) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1981.10471447 · Cited by 261
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites
Turcotte, C., Chouinard, F., Lefebvre, J. S., & Flamand, N. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0115-021r · Cited by 258
The fatty acid amide hydrolase (FAAH)
Ueda, N., Puffenbarger, R. A., Yamamoto, S., & Deutsch, D. G. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00190-0 · Cited by 256
Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status
Everard, A., Geurts, L., Caesar, R., Hul, M. V., Matamoros, S., Duparc, T., Denis, R., Cochez, P. M., Pierard, F., Castel, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6648 · Cited by 245
The Palmitoylethanolamide and Oleamide Enigmas: Are These Two Fatty Acid Amides Cannabimimetic?
Lambert, D. M., & Marzo, V. D. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401153732 · Cited by 244
Metabolism of endocannabinoids and related N ‐acylethanolamines: Canonical and alternative pathways
Ueda, N., Tsuboi, K., & Uyama, T. (2013) · FEBS Journal · doi:10.1111/febs.12152 · Cited by 242
A Crypt-Specific Core Microbiota Resides in the Mouse Colon
Pédron, T., Mulet, C., Dauga, C., Frangeul, L., Chervaux, C., Grompone, G., & Sansonetti, P. J. (2012) · mBio · doi:10.1128/mbio.00116-12 · Cited by 234
Lipopolysaccharide Induces Anandamide Synthesis in Macrophages via CD14/MAPK/Phosphoinositide 3-Kinase/NF-κB Independently of Platelet-activating Factor
Liu, J., Bátkai, S., Pacher, P., Harvey-White, J. D., Wagner, J. A., Cravatt, B. F., Gao, B., & Kunos, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306062200 · Cited by 234
Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels
PETROCELLIS, L. D., & Marzo, V. D. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9177-z · Cited by 223
CB1 Signaling in Forebrain and Sympathetic Neurons Is a Key Determinant of Endocannabinoid Actions on Energy Balance
Quarta, C., Bellocchio, L., Mancini, G., Mazza, R., Cervino, C., Braulke, L. J., Fekete, C., Latorre, R., Nanni, C., Bucci, M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.02.015 · Cited by 217
Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors
Goparaju, S. K., Ueda, N., Taniguchi, K., & Yamamoto, S. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00314-1 · Cited by 212
The Endogenous Cannabinoid System Stimulates Glucose Uptake in Human Fat Cells via Phosphatidylinositol 3-Kinase and Calcium-Dependent Mechanisms
Pagano, C., Pilon, C., Calcagno, A., Urbanet, R., Rossato, M., Milan, G., Bianchi, K., Rizzuto, R., Bernante, P., Federspil, G., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0768 · Cited by 209
The fatty acid amide hydrolase (FAAH)
Deutsch, D. G., Ueda, N., & Yamamoto, S. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0358 · Cited by 209
Increasing endogenous 2‐arachidonoylglycerol levels counteracts colitis and related systemic inflammation
Alhouayek, M., Lambert, D. M., Delzenne, N. M., Cani, P. D., & Muccioli, G. G. (2011) · The FASEB Journal · doi:10.1096/fj.10-176602 · Cited by 208
High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals
Ringel, Y., Maharshak, N., Ringel‐Kulka, T., Wolber, E. A., Sartor, R. B., & Carroll, I. M. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1044711 · Cited by 203
The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide
Marzo, V. D., Bisogno, T., SUGIURA, T., Melck, D. J., & PETROCELLIS, L. D. (1998) · Biochemical Journal · doi:10.1042/bj3310015 · Cited by 199
Hashish—IV
Mechoulam, R., & Gaoni, Y. (1965) · Tetrahedron · doi:10.1016/0040-4020(65)80064-3 · Cited by 197
Endocannabinoids as Regulators of Transient Receptor Potential (TRP)Channels: a Further Opportunity to Develop New Endocannabinoid-Based Therapeutic Drugs
Marzo, V. D., & PETROCELLIS, L. D. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980078 · Cited by 197
Endocannabinoids in liver disease
Tam, J., Liu, J., Mukhopadhyay, B., Çınar, R., Godlewski, G., & Kunos, G. (2010) · Hepatology · doi:10.1002/hep.24077 · Cited by 196
Endocannabinoid biosynthesis and inactivation, from simple to complex
Muccioli, G. G. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.03.007 · Cited by 192
Endocannabinoids, Related Compounds and Their Metabolic Routes
Fezza, F., Bari, M., Florio, R., Talamonti, E., Feole, M., & Maccarrone, M. (2014) · Molecules · doi:10.3390/molecules191117078 · Cited by 187
A fatty gut feeling
Piomelli, D. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.03.001 · Cited by 185
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti‐inflammatory agent
Borrelli, F., Romano, B., Petrosino, S., Pagano, E., Capasso, R., Coppola, D., Battista, G., Orlando, P., Marzo, V. D., & Izzo, A. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12907 · Cited by 182
Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota
Geurts, L., Everard, A., Hul, M. V., Essaghir, A., Duparc, T., Matamoros, S., Plovier, H., Castel, J., Denis, R., Bergiers, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7495 · Cited by 172
α/β-Hydrolase Domain-6-Accessible Monoacylglycerol Controls Glucose-Stimulated Insulin Secretion
Zhao, S., Mugabo, Y., Iglesias, J., Xie, L., Delghingaro‐Augusto, V., Lussier, R., Peyot, M., Joly, E. C., Taïb, B., Davis, M. A., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.003 · Cited by 166
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re‐feeding
Izzo, A. A., Piscitelli, F., Capasso, R., Aviello, G., Romano, B., Borrelli, F., Petrosino, S., & Marzo, V. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00183.x · Cited by 164
Lipopolysaccharide Downregulates Fatty Acid Amide Hydrolase Expression and Increases Anandamide Levels in Human Peripheral Lymphocytes
Maccarrone, M., PETROCELLIS, L. D., Bari, M., Fezza, F., Salvati, S., Marzo, V. D., & Finazzi‐Agrò, A. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2500 · Cited by 162
The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?
Bermúdez‐Silva, F. J., Viveros, M., McPartland, J. M., & de Fonseca, F. R. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.03.012 · Cited by 160
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6
Alhouayek, M., Masquelier, J., Cani, P. D., Lambert, D. M., & Muccioli, G. G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314017110 · Cited by 152
MabsBase: A Mycobacterium abscessus Genome and Annotation Database
Heydari, H., Wee, W. Y., Lokanathan, N., Hari, R., Yusoff, A. M., Beh, C. Y., Yazdi, A. H., Wong, G. J., Ngeow, Y. F., & Choo, S. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062443 · Cited by 151
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines
Brown, I. M., Cascio, M. G., Wahle, K. W. J., Smoum, R., Mechoulam, R., Ross, R. A., Pertwee, R. G., & Heys, S. D. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq151 · Cited by 150
N-acylphosphatidylethanolamine, a Gut- Derived Circulating Factor Induced by Fat Ingestion, Inhibits Food Intake
Gillum, M. P., Zhang, D., Zhang, X., Erion, D. M., Jamison, R. A., Choi, C., Dong, J., Shanabrough, M., Duenas, H. R., Frederick, D. W., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.043 · Cited by 145
Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons
Cristino, L., Busetto, G., Imperatore, R., Ferrandino, I., Palomba, L., Silvestri, C., Petrosino, S., Orlando, P., Bentivoglio, M., Mackie, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219485110 · Cited by 143
Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability
Alhamoruni, A., Lee, A. C., Wright, K. L., Larvin, M., & O’Sullivan, S. E. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168237 · Cited by 140
Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond
Cani, P. D., Geurts, L., Matamoros, S., Plovier, H., & Duparc, T. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.02.004 · Cited by 139
Cannabinoids mediate opposing effects on inflammation‐induced intestinal permeability
Alhamoruni, A., Wright, K. L., Larvin, M., & O’Sullivan, S. E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01589.x · Cited by 138
Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide
Cani, P. D., Montoya, M. L., Neyrinck, A. M., Delzenne, N. M., & Lambert, D. M. (2004) · British Journal Of Nutrition · doi:10.1079/bjn20041256 · Cited by 136
Proteome-Wide Reactivity Profiling Identifies Diverse Carbamate Chemotypes Tuned for Serine Hydrolase Inhibition
Chang, J. W., Cognetta, A. B., Niphakis, M. J., & Cravatt, B. F. (2013) · ACS Chemical Biology · doi:10.1021/cb400261h · Cited by 134
The Serine Hydrolase ABHD6 Is a Critical Regulator of the Metabolic Syndrome
Thomas, G., Betters, J. L., Lord, C. C., Brown, A. L., Marshall, S., Ferguson, D., Sawyer, J. K., Davis, M. A., Melchior, J., Blume, L. C., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.047 · Cited by 129
Endocannabinoids and energy homeostasis: An update
Cristino, L., Becker, T., & Marzo, V. D. (2014) · BioFactors · doi:10.1002/biof.1168 · Cited by 125
Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases
Urquhart, P., Nicolaou, A., & Woodward, D. F. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.015 · Cited by 125
Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice
LoVerme, J., Duranti, A., Tontini, A., Spadoni, G., Mor, M., Rivara, S., Stella, N., Xu, C., Tarzia, G., & Piomelli, D. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.059 · Cited by 124
Development of the first potent and specific inhibitors of endocannabinoid biosynthesis
Bisogno, T., Cascio, M. G., Saha, B., Mahadevan, A., Urbani, P., Minassi, A., Appendino, G., Saturnino, C., Martin, B. R., & Razdan, R. K. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.12.009 · Cited by 124
Harnessing the anti-inflammatory potential of palmitoylethanolamide
Alhouayek, M., & Muccioli, G. G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.007 · Cited by 123
Regulation of GPR119 receptor activity with endocannabinoid-like lipids
Syed, S. K., Bui, H. H., Beavers, L. S., Farb, T. B., FICORILLI, J. V., Chesterfield, A. K., Kuo, M., Bokvist, K. B., Barrett, D. G., & Efanov, A. M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00269.2012 · Cited by 122
A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome
Bowles, N. P., Karatsoreos, I. N., Li, X., Vemuri, K. V., Wood, J.-A., Li, Z., Tamashiro, K. L., Schwartz, G. J., Makriyannis, A., Kunos, G., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421420112 · Cited by 111
Endocannabinoid overactivity and intestinal inflammation
Marzo, V. D., & Izzo, A. A. (2006) · Gut · doi:10.1136/gut.2005.090472 · Cited by 108
Stearoylethanolamide exerts anorexic effects in mice via downregulation of liver stearoyl‐coenzyme A desaturase‐1 mRNA expression
Terrazzino, S., Berto, F., Carbonare, M. D., Fabris, M., Guiotto, A., Bernardini, D., & Leon, A. (2004) · The FASEB Journal · doi:10.1096/fj.03-1080fje · Cited by 105
N ‐Acylethanolamine‐hydrolyzing acid amidase inhibition increases colon N ‐palmitoylethanolamine levels and counteracts murine colitis
Alhouayek, M., Bottemanne, P., Subramanian, K. V., Lambert, D. M., Makriyannis, A., Cani, P. D., & Muccioli, G. G. (2014) · The FASEB Journal · doi:10.1096/fj.14-255208 · Cited by 103
The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high‐fat diet
Marzo, V. D., Capasso, R., Matias, I., Aviello, G., Petrosino, S., Borrelli, F., Romano, B., Orlando, P., Capasso, F., & Izzo, A. A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707682 · Cited by 102
Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects
Banni, S., Carta, G., Murru, E., Cordeddu, L., Giordano, E., Sirigu, A. R., Berge, K., Vik, H., Maki, K. C., Marzo, V. D., et al. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-7 · Cited by 102
Intestinal lipid–derived signals that sense dietary fat
DiPatrizio, N. V., & Piomelli, D. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76302 · Cited by 100
Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice
Bajzer, M., Olivieri, M., Haas, M. K., Pfluger, P. T., Magrisso, I. J., Foster, M. T., Tschöp, M. H., Carhuatanta, K. A. K., Cota, D., & Obici, S. (2011) · Diabetologia · doi:10.1007/s00125-011-2302-6 · Cited by 99
The therapeutic potential of GPR119 agonists for type 2 diabetes
Ohishi, T., & Yoshida, S. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.657797 · Cited by 99
Peripherally restricted CB1 receptor blockers
Chorvat, R. J. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.06.066 · Cited by 99
FAAH deficiency promotes energy storage and enhances the motivation for food
Touriño, C., Oveisi, F., Lockney, J., Piomelli, D., & Maldonado, R. J. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.262 · Cited by 87
Proinflammatory Stimuli Control N-Acylphosphatidylethanolamine-Specific Phospholipase D Expression in Macrophages
Zhu, C., Solorzano, C., Sahar, S., Realini, N., Fung, E. S., Sassone‐Corsi, P., & Piomelli, D. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070201 · Cited by 86
Palmitoylethanolamide normalizes intestinal motility in a model of post‐inflammatory accelerated transit: involvement of CB 1 receptors and TRPV 1 channels
Capasso, R., Orlando, P., Pagano, E., Aveta, T., Buono, L., Borrelli, F., Marzo, V. D., & Izzo, A. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12759 · Cited by 85
Fat to treat fat: Emerging relationship between dietary PUFA, endocannabinoids, and obesity
Kim, J. J., Li, Y., & Watkins, B. A. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.11.005 · Cited by 77
Peripheral selectivity of the novel cannabinoid receptor antagonist TM 38837 in healthy subjects
Klumpers, L. E., Fridberg, M., de Kam, M. L., Little, P. B., Jensen, N. O., Kleinloog, H. D., Elling, C., & van Gerven, J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12141 · Cited by 77
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2‐arachidonoylglycerol with potential anti‐obesity effects
Bisogno, T., Mahadevan, A., Coccurello, R., Chang, J. W., Allarà, M., Chen, Y., Giacovazzo, G., Lichtman, A. H., Cravatt, B. F., Moles, A., et al. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12013 · Cited by 74
Dietary DHA reduces downstream endocannabinoid and inflammatory gene expression and epididymal fat mass while improving aspects of glucose use in muscle in C57BL/6J mice
Kim, J., Carlson, M. E., Kuchel, G. A., Newman, J. W. I., & Watkins, B. A. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.135 · Cited by 73
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells
Gibellini, L., Pinti, M., Boraldi, F., Giorgio, V., Bernardi, P., Bartolomeo, R., Nasi, M., Biasi, S. D., Missiroli, S., Carnevale, G., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-255869 · Cited by 73
Altered endocannabinoid signalling after a high-fat diet in Apoe −/− mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance
Bartelt, A., Orlando, P., Mele, C., Ligresti, A., Toedter, K., Scheja, L., Heeren, J., & Marzo, V. D. (2011) · Diabetologia · doi:10.1007/s00125-011-2274-6 · Cited by 71
Prospective therapeutic agents for obesity: Molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists
Sharma, M. K., Murumkar, P. R., Kanhed, A. M., Giridhar, R., & Yadav, M. R. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.011 · Cited by 70
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P
Guagnini, F., Valenti, M., Mukenge, S., Matias, I., Bianchetti, A., Palo, S. D., Ferla, G., Marzo, V. D., & Croci, T. (2006) · Gut · doi:10.1136/gut.2005.076372 · Cited by 68
Anti‐inflammatory Effect of Palmitoylethanolamide on Human Adipocytes
Hoareau, L., Buyse, M., Festy, F., Ravanan, P., Gonthier, M., Matias, I., Petrosino, S., Tallet, F., d’Hellencourt, C. L., Césari, M., et al. (2009) · Obesity · doi:10.1038/oby.2008.591 · Cited by 68
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats
D’Argenio, G., Petrosino, S., Gianfrani, C., Valenti, M., Scaglione, G., Grandone, I., Nigam, S., Sorrentini, I., Mazzarella, G., & Marzo, V. D. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0192-3 · Cited by 67
Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat
Suárez, J., Rivera, P., Arrabal, S., Crespillo, A., Serrano, A., Baixerás, E., Pavón, F. J., Cifuentes, M., Nogueiras, R., Ballesteros, J., et al. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.013110 · Cited by 63
Advances in the discovery of N-acylethanolamine acid amidase inhibitors
Bandiera, T., Ponzano, S., & Piomelli, D. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.04.011 · Cited by 60
Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents
Igarashi, M., DiPatrizio, N. V., Narayanaswami, V., & Piomelli, D. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.05.006 · Cited by 59
Keeping gut lining at bay: impact of emulsifiers
Cani, P. D., & Everard, A. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.03.009 · Cited by 55
Diacylglycerol Lipase α Knockout Mice Demonstrate Metabolic and Behavioral Phenotypes Similar to Those of Cannabinoid Receptor 1 Knockout Mice
Powell, D. R., Gay, J. P., Wilganowski, N. L., Doree, D. D., Savelieva, K. V., Lanthorn, T. H., Read, R. W., Vogel, P., Hansen, G. M., Brommage, R., et al. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00086 · Cited by 50
Analysis of the “endocannabinoidome” in peripheral tissues of obese Zucker rats
Iannotti, F. A., Piscitelli, F., Martella, A., Mazzarella, E., Allarà, M., Palmieri, V., Parrella, C., Capasso, R., & Marzo, V. D. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.06.002 · Cited by 50
Synthesis and Pharmacological Activity of a Potent Inhibitor of the Biosynthesis of the Endocannabinoid 2‐Arachidonoylglycerol
Bisogno, T., Burston, J. J., Rai, R., Allarà, M., Saha, B., Mahadevan, A., Razdan, R. K., Wiley, J. L., & Marzo, V. D. (2009) · ChemMedChem · doi:10.1002/cmdc.200800442 · Cited by 50
Palmitoylethanolamide Prevents Metabolic Alterations and Restores Leptin Sensitivity in Ovariectomized Rats
Raso, G. M., Santoro, A. N., Russo, R., Simeoli, R., Paciello, O., Carlo, C. D., Diano, S., Calignano, A., & Meli, R. (2014) · Endocrinology · doi:10.1210/en.2013-1823 · Cited by 48
Monitoring host responses to the gut microbiota
Lichtman, J. S., Sonnenburg, J. L., & Elias, J. E. (2015) · The ISME Journal · doi:10.1038/ismej.2015.93 · Cited by 44
Chronic Endocannabinoid System Stimulation Induces Muscle Macrophage and Lipid Accumulation in Type 2 Diabetic Mice Independently of Metabolic Endotoxaemia
Geurts, L., Muccioli, G. G., Delzenne, N. M., & Cani, P. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055963 · Cited by 41
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines
Brown, I. M., Wahle, K. W. J., Cascio, M. G., Smoum, R., Mechoulam, R., Pertwee, R. G., & Heys, S. D. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.09.007 · Cited by 40
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract
Sałaga, M., Sobczak, M., & Fichna, J. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.11.012 · Cited by 39
The endocannabinoidome : the world of endocannabinoids and related mediators
Marzo, V. D., & Wang, J. Y. (2015) · Cited by 38
Optimization of 1,2,5‐Thiadiazole Carbamates as Potent and Selective ABHD6 Inhibitors
Patel, J. Z., Nevalainen, T., Savinainen, J. R., Adams, Y., Laitinen, T., Runyon, R. S., Vaara, M., Ahenkorah, S., Kaczor, A. A., Navia‐Paldanius, D., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201402453 · Cited by 38
Modulation of Glucagon-like Peptide-1 (GLP-1) Potency by Endocannabinoid-like Lipids Represents a Novel Mode of Regulating GLP-1 Receptor Signaling
Cheng, R. Y.-H., Ho, M., Huang, W., Chou, Y.-T., & King, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.655662 · Cited by 38
Discovery of Glycine Sulfonamides as Dual Inhibitors ofsn-1-Diacylglycerol Lipase α and α/β-Hydrolase Domain 6
Janssen, F. J., Deng, H., Baggelaar, M. P., Allarà, M., van der Wel, T., den Dulk, H., Ligresti, A., van Esbroeck, A. C. M., McGuire, R., Marzo, V. D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500681z · Cited by 34
A Common Haplotype in NAPEPLD Is Associated With Severe Obesity in a Norwegian Population‐Based Cohort (the HUNT Study)
Wangensteen, T., Akselsen, H. E., Holmen, J., Undlien, D. E., & Retterstøl, L. (2010) · Obesity · doi:10.1038/oby.2010.219 · Cited by 33
A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents
Sharma, M. K., Murumkar, P. R., Barmade, M. A., Giridhar, R., & Yadav, M. R. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1064898 · Cited by 31
Acute Activation of Cannabinoid Receptors by Anandamide Reduces Gastrointestinal Motility and Improves Postprandial Glycemia in Mice
Troy-Fioramonti, S., Demizieux, L., Gresti, J., Muller, T., Vergès, B. L., & Degrace, P. (2014) · Diabetes · doi:10.2337/db14-0721 · Cited by 18
GASTROINTESTINAL ENDOCANNABINOID SYSTEM: MULTIFACETED ROLES IN THE HEALTHY AND INFLAMED INTESTINE
Smid, S. D. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05016.x · Cited by 15

Flagged first, then by citations

Sorted by citations

Gut microbiome and health: mechanistic insights
de Vos, W. M., Tilg, H., Van Hul, M., & Cani, P. D. (2022) · Gut · doi:10.1136/gutjnl-2021-326789 · Cited by 2,388
A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice
Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N., Duparc, T., Lichtenstein, L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4236 · Cited by 2,204
Self-citation
Neurotransmitter modulation by the gut microbiota
Strandwitz, P. (2018) · Brain Research · doi:10.1016/j.brainres.2018.03.015 · Cited by 1,527
Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
Cani, P. D., & de Vos, W. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01765 · Cited by 1,058
“We then discovered that live A. muciniphila increased the endogenous production of specific bioactive lipids that belongs to the endocannabinoid family and are known to have anti-inflammatory activities and regulating the endogenous production of gut peptides involved in glucose regulation and gut barrier, respectivel…”
Background
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Cristino, L., Bisogno, T., & Di Marzo, V. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0284-z · Cited by 970

See all 367

Authors: Cani, P. D., Plovier, H., Van Hul, M., Geurts, L., Delzenne, N. M., Druart, C., & Everard, A.
Affiliations: Walloon Excellence in Lifesciences and Biotechnology (BE)
UCLouvain (BE)
Corresponding author: Cani, Patrice D.
ORCID: Cani, Patrice D.
Plovier, Hubert
Geurts, Lucie
Delzenne, Nathalie M.
Druart, Céline
Everard, Amandine
Venue: Nature Reviews Endocrinology
Publisher: Springer Science and Business Media LLC
Published: 2015-12-18
Volume: 12
Issue: 3
Pages: 133-143
ISSN: 1759-5029 (ISSN-L)
1759-5037
DOI: 10.1038/nrendo.2015.211
OpenAlex: W2206708469
Cited by: 367
References: 156
Citations by year: 2026: 23 · 2025: 30 · 2024: 27 · 2023: 37 · 2022: 51 · 2021: 55 · 2020: 45 · 2019: 25 · 2018: 30 · 2017: 24 · 2016: 20
FWCI: 3.09
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Endocrinology (publishedVersion)
PubMed (publishedVersion)
Digital Access to Libraries (submittedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: endocannabinoid system, gut microbiota, host metabolism, intestinal permeability, intestinal barrier, bioactive lipids, obesity, adipose tissue, type 2 diabetes, cardiometabolic disease, intestinal inflammation, fat mass
MeSH terms: Gastrointestinal Microbiome, Animals, Humans, Gastrointestinal Tract, Receptors, Cannabinoid, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Endocannabinoids–at the crossroads between the gut microbiota and host metabolism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks